Digestive & Intestinal Remedies (Pharmacies) - Worldwide

Revenue in the Digestives & Intestinal Remedies market is projected to reach US$16.04bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 3.02%, resulting in a market volume of US$18.62bn by 2029.
In global comparison, most revenue will be generated China (US$3.37bn in 2024).
In relation to total population figures, per person revenues of US$2.07 are generated in 2024.

Definition:
The Digestives and Intestinal Remedies market encompasses a range of over-the-counter (OTC) natural and synthetic digestive agents and remedies designed to address gastrointestinal concerns. These products are available through pharmacies and are provided in various forms such as pills, powder, capsules, liquids, solutions, suspensions, drops, and suppositories. The market excludes prescription medications, substances contravening state regulations, or items not explicitly categorized as digestive medications (e.g., pain relievers). Notable among the best-selling products in this category are Perenterol, Iberogast, Dulcolax, and Buscopan Plus. This market exclusively covers product sales through pharmacies.

Additional information:
The Digestives and Intestinal Remedies market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Digestive medicines
Remedies against gastrointestinal complaints

Prescription medicines
Homeopathic remedies
Tea

The Digestive & Intestinal Remedies market in worldwide is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to this growth. Customer preferences play a crucial role in the development of the Digestive & Intestinal Remedies market. Consumers are increasingly seeking natural and organic remedies for digestive and intestinal issues. They are becoming more conscious of the ingredients and potential side effects of pharmaceutical products, leading to a shift towards natural alternatives. This preference for natural remedies is driving the demand for herbal and homeopathic Digestive & Intestinal Remedies. Trends in the market also contribute to the growth of the Digestive & Intestinal Remedies market. One prominent trend is the increasing prevalence of digestive disorders worldwide. Factors such as unhealthy diets, sedentary lifestyles, and high-stress levels contribute to the rise in digestive issues. As a result, there is a growing need for effective remedies to alleviate symptoms and improve digestive health. This trend is driving the demand for Digestive & Intestinal Remedies in the market. Local special circumstances vary from country to country and can impact the development of the Digestive & Intestinal Remedies market. For example, in countries with aging populations, there is a higher prevalence of digestive issues among the elderly. This demographic trend creates a specific market segment that requires targeted digestive remedies. Additionally, cultural factors can influence the demand for Digestive & Intestinal Remedies. For instance, countries with a strong tradition of herbal medicine may have a higher demand for natural remedies. Underlying macroeconomic factors also play a significant role in the development of the Digestive & Intestinal Remedies market. Economic growth and rising disposable incomes contribute to increased healthcare spending, including spending on digestive remedies. As economies develop, individuals have more access to healthcare services and are more likely to seek treatment for digestive issues. This drives the demand for Digestive & Intestinal Remedies in the market. In conclusion, the Digestive & Intestinal Remedies market in worldwide is experiencing growth and development due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The shift towards natural remedies, the increasing prevalence of digestive disorders, specific market segments, and economic growth all contribute to the growth of this market.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.